{
    "ucits": false,
    "type": "ETP",
    "leverage": true,
    "derivatives": true,
    "swaps": false,
    "inverse": true,
    "replication_method": "synthetic",
    "complex_factors": [
        "Leverage -3x inverse exposure",
        "Synthetic replication via index with derivatives",
        "Daily leverage rebalancing and compounding effects",
        "High risk (7/7 risk indicator)",
        "Complex payoff structure with inverse leveraged exposure",
        "Potential counterparty and collateral risks",
        "Short recommended holding period (1 day)",
        "No capital protection",
        "Illiquidity and possible early redemption events"
    ],
    "classification": "complex",
    "supporting_data": "The product is a -3x short leveraged ETP on Taiwan Semiconductor ADR, aiming to deliver -3 times the daily performance of the underlying equity. It uses a synthetic replication method tracking the iSTOXX Inverse Leveraged -3x TSM Index, which implies use of derivatives integral to the strategy. The product is collateralised but exposes investors to counterparty and collateral risks inherent in synthetic replication. The leverage factor of -3x and inverse exposure significantly increase complexity and risk, as does the daily rebalancing causing compounding effects that retail investors with basic knowledge are unlikely to understand. The risk indicator is at the highest level (7/7), reflecting very high risk. The product is not capital protected and has a recommended holding period of only 1 day due to the complexity of returns over longer periods. The structure, risks, and payoff profile are opaque and require advanced understanding of derivatives, leverage, and compounding. According to MiFID II Article 254, Delegated Regulation EU 2017/565 Article 57, and ESMA guidelines, such features classify the product as complex. UCITS ETFs are generally non-complex, but this product is an ETP security, not a UCITS fund, and its leverage, synthetic replication, and inverse leveraged exposure make it complex. Therefore, an appropriateness assessment is required before sale to retail investors."
}